HTB

Research studies

Switch study for people with insomnia using dolutegravir

START study: call for participants to attend final visit – please help…

IAS 2021: Proving efficacy of next generation PrEP: counterfactual controls in lenacapavir and islatravir studies

UK study for people with triple-class drug resistance

US requires informed consent forms for clinical studies to be posted online

How to evaluate PrEP and vaccines: urgency for next generation compounds

ViiV announces phase 3 study switching to dolutegravir/3TC dual therapy from TAF-containing ART

Updates from the PrEP IMPACT study – November 2017

Exercise associated with significantly reduced risk of serious health problems and higher CD4 counts in large multicentre US study

Non-AIDS mortality in England and Wales in HIV positive vs general population

Why START would make an excellent long-term cohort

Why dolutegravir might get us closer to ending AIDS: next step, further research

UK PROUD study to provide PrEP earlier than expected: planned follow-up to continue to two years